Trials / NCT03281005
Development of Visual Function Evaluation Method
Completed Observational Natural history / observational
- Sponsor
- Astellas Pharma Inc
- Treatment
- Not listed
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 20 Years to no upper limit
- Enrollment
- 18 participants
- Started
- 2017-11-01
- Main results expected
- 2019-11-21
- Results posted
- Not yet
- Record last updated
- 2024-10-21
What the study is testing
The objective of this study is to develop the comprehensive visual function evaluation method in severe visually impaired patient
Where it runs
Japan (1)
- Site JP00001, Meguro-ku, Tokyo